Boardroom Alpha
Boardroom Alpha
DHR · Current Report (Form 8-K) · Filed June 3, 2026

Danaher Corp — Current Report (Form 8-K)

Form
8-K
Filed
June 3, 2026
Period
Jun 3, 2026
Ticker
DHR
Accession
0001193125-26-255555
Boardroom Alpha · Filing insights

Danaher and DH Masi Finance sold multiple CHF senior notes in a private placement; proceeds for general corporate purposes.

About Danaher Corp
Market cap
$151.9B
1Y TSR
+1.7%
3Y TSR
−2.5%
Board grade
C
Sector
Healthcare
CEO
Montgomery Julie A Sawyer
Last annual meeting: May 5, 2026 · View full Danaher Corp profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 3, 2026

 

 

 

LOGO

DANAHER CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-08089   59-1995548
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

2200 Pennsylvania Avenue, N.W.,

Suite 800W

 
Washington, DC   20037-1701
(Address of Principal Executive Offices)   (Zip Code)

202-828-0850

(Registrant’s Telephone Number, Including Area Code)

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common stock, $0.01 par value   DHR   New York Stock Exchange
0.200% Senior Notes due 2026   DHR/26   New York Stock Exchange
2.100% Senior Notes due 2026   DHR 26   New York Stock Exchange
1.200% Senior Notes due 2027   DHR/27   New York Stock Exchange
0.450% Senior Notes due 2028   DHR/28   New York Stock Exchange
Floating Rate Senior Notes due 2028   DHR 28   New York Stock Exchange
2.500% Senior Notes due 2030   DHR 30   New York Stock Exchange
3.250% Senior Notes due 2030   DHR 30A   New York Stock Exchange
0.750% Senior Notes due 2031   DHR/31   New York Stock Exchange
3.625% Senior Notes due 2034   DHR 34   New York Stock Exchange
4.000% Senior Notes due 2038   DHR 38   New York Stock Exchange
1.350% Senior Notes due 2039   DHR/39   New York Stock Exchange
1.800% Senior Notes due 2049   DHR/49   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


ITEM 2.03 CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

Reference is made to the disclosure set forth under Item 8.01 below, which is incorporated herein by reference.

ITEM 8.01 OTHER EVENTS.

On June 3, 2026, Danaher Corporation, a Delaware corporation (the “Company”), and its wholly owned subsidiary DH Masi Finance Inc., a Delaware corporation (the “Issuer”), entered into a note purchase and guaranty agreement among the Company, the Issuer and the institutional accredited investors named therein (the “Note Purchase Agreement”), relating to the issuance and sale of (i) CHF 119,500,000 aggregate principal amount of the Issuer’s 1.65% Senior Notes, Series A due June 3, 2031 (the “Series A Notes”), (ii) CHF 137,410,000 aggregate principal amount of the Issuer’s 1.88% Senior Notes, Series B due June 3, 2033 (the “Series B Notes”), (iii) CHF 221,300,000 aggregate principal amount of the Issuer’s 2.10% Senior Notes, Series C due June 3, 2036 (the “Series C Notes”), (iv) CHF 372,660,000 aggregate principal amount of the Issuer’s 2.25% Senior Notes, Series D due June 3, 2038 (the “Series D Notes”), (v) CHF 648,010,000 aggregate principal amount of the Issuer’s 2.38% Senior Notes, Series E due June 3, 2041 (the “Series E Notes”), (vi) CHF 502,060,000 aggregate principal amount of the Issuer’s 2.51% Senior Notes, Series F due June 3, 2046 (the “Series F Notes”), and (vii) CHF 382,000,000 aggregate principal amount of the Issuer’s 2.50% Senior Notes, Series G due June 3, 2056 (the “Series G Notes” collectively with the Series A Notes, the Series B Notes, the Series C Notes, the Series D Notes, the Series E Notes and the Series F Notes, the “Notes”) in an offering exempt from the registration requirements of the Securities Act of 1933, as amended. Closing of the issuance and sale of the Notes occurred on June 3, 2026. The net proceeds from the sale of the Notes are expected to be used for general corporate purposes of the Company and the Issuer (including working capital expenditures, acquisitions and share repurchases).

The Note Purchase Agreement contains customary terms and conditions for senior unsecured notes issued in a private placement, including, without limitation, affirmative and negative covenants, events of default, prepayment and other standard terms and conditions, many of which are generally consistent with terms and conditions of the Company’s other debt obligations, including, but not limited to, those under its existing credit facilities.

The Series A Notes will mature on June 3, 2031 and bear a fixed interest rate of 1.65% per year. The Series B Notes will mature on June 3, 2033 and bear a fixed interest rate of 1.88% per year. The Series C Notes will mature on June 3, 2036 and bear a fixed interest rate of 2.10% per year. The Series D Notes will mature on June 3, 2038 and bear a fixed interest rate of 2.25% per year. The Series E Notes will mature on June 3, 2041 and bear a fixed interest rate of 2.38% per year. The Series F Notes will mature on June 3, 2046 and bear a fixed interest rate of 2.51% per year. The Series G Notes will mature on June 3, 2056 and bear a fixed interest rate of 2.50% per year. Interest on each series of Notes is payable semi-annually on June 3 and December 3 of each year, commencing December 3, 2026. The Notes are unsecured obligations of the Issuer and are fully and unconditionally guaranteed by the Company.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 3, 2026

 

DANAHER CORPORATION

/s/ James F. O’Reilly

Name: James F. O’Reilly
Title: Senior Vice President, Secretary and Deputy General Counsel
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Danaher Corp (DHR)

Reference

Frequently asked questions

When did Danaher Corp file this 8-K?
Danaher Corp (DHR) filed this Current Report (Form 8-K) with the SEC on June 3, 2026. The accession number assigned by EDGAR is 0001193125-26-255555.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Danaher and DH Masi Finance sold multiple CHF senior notes in a private placement; proceeds for general corporate purposes. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Danaher Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Danaher Corp has filed under CIK 313616, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer